NASDAQ: OCUL · Health Care / Biotechnology: Pharmaceutical Preparations

Ocular Therapeutix Inc.

How Ocular Therapeutix Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$1.6B

Price

$7.31

P/E

-5.3

EPS (TTM)

$-1.37

1-year return

-36.3%

Dividend yield

0.0%

52-week range

$6.29–$11.72

Compared with

• Biotechnology: Pharmaceutical Preparations industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources